NorthWest Biotherapeutics Inc (NWBO)

[CherryTree1]

This is a slam dunk EX.
I am sure people are getting tired of me posting this but it is irrefutable so here it is 1 more time.

We already know the top line results will be positive, at least this good from the still blinded data on all 331 patients
https://nwbio.com/updated-interim-data-from-phase-3-trial-of-dcvax-l-for-glioblastoma/

Survival at 3 years is 28.2%
Survival at 3 years for 41.1% (methylated)

The historical GBM SOC survival
https://www.nature.com/articles/s41598-020-68011-4#:~:text=%25%2C%20respectively36.-,Discussion,glioblastoma%20during%20or%20after%202005.

3-year survival was 11%,
and 5-year survival was 4%

We know from updates to the European website European website's several weeks ago that the primary end point has changed to compare DCVAX treat patients to to recent historical SOC for GBM overall survival.

If the regulatory agencies play this straight and are not in the pocket of the big money thugs this is a slam dunk for accelerated approval.. It is fortunate that we have regulatory agencies in the USA and Europe dealing with this because one would hope that they can't all be compromised.